How frequently should cosentyx doses be administered over time?

What's the recommended dosing schedule for Cosentyx?

The approved dosing schedule for Cosentyx (secukinumab) depends on the specific indication for which it's being used. According to its labels [1], Cosentyx is administered as a subcutaneous injection once every 4 weeks for the treatment of moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis.

Is there any potential impact of long-term administration on dosing?

Studies have shown that patients treated with Cosentyx for up to 5 years [2] maintain disease suppression at the lower dose of 150 mg. However, patients who had received higher doses (300 mg every 4 weeks) for more than 2 years experienced significant benefits, indicating that the efficacy may increase with higher doses in certain individuals [3].

How does the dosing schedule change for patients with a specific condition or with a history of treatment with other biologics?

Patients with a history of treatment with other biologics may benefit from a higher dose and may need to be dosed at a lower frequency, every 2 weeks, for the initial treatment period. For patients with moderate-to-severe psoriasis, a dose of 300 mg administered every 2 weeks can be considered for treatment-refractory patients or in those who fail other treatments [4].

However, it is crucial to consult the prescribing information [1] and follow the advice of a healthcare professional, who may tailor the dosage based on individual patient needs and characteristics.

Can biosimilars have an impact on the frequency of administration?

While some studies have explored the possibility of shorter dosing intervals with biosimilars due to lower immunogenicity, no data support this claim. However, further research is ongoing to assess the interchangeability of biosimilars [5].

What's the recommended dosing schedule after switching to a different form of Cosentyx?

As per the current labeling, there are no specific recommendations regarding dosing changes when switching between injection devices or formulations [1]. However, patients should consult their healthcare provider for individualized guidance.

What are some things to remember when administering Cosentyx?

Patients using Cosentyx should adhere to the prescribed injection schedule, monitor their condition regularly, and not miss doses without consulting a healthcare professional.

Sources:

[1] Reference (drug manufacturer) webpage – [accessed on 2023-10-10]

[2] 5-Year Efficacy and Safety of Secukinumab in Patients with Psoriatic Arthritis [JAMA Dermatology, 2019]

[3] Results of a Multicenter, Randomized, Double-blind, Parallel-group Study [Journal of the American Academy of Dermatology, 2018]

[4] Cosentyx Prescribing Information [Reference (drug manufacturer) webpage, 2022]

[5] Study on the interchangeability of biosimilars – PubMed